SARS-CoV-2 Delta Variant Poised to Acquire Complete Resistance” to the Existing Vaccines: Japanese Study By Brian Simpson
Japanese research is indicating that SARS-CoV-2 Delta variant “is poised to acquire complete resistance” to the existing vaccines. So, what does that mean for the Australian position? Well it is back to the drawing boards, as the country is locked down until the new vaccine, which will also soon be useless because of mutations. Thus, either Australia goes the way of natural immunity, or faces economic collapse. If the ICUs get overwhelmed, that is just the cost we should face. Build more, using all those vacant buildings from businesses that have gone bankrupt from the lockdowns.
“Covid-19 injections continue to be pushed as the only solution to the pandemic, even as “breakthrough” infections increasingly occur. But a group of Japanese researchers have released a scientific study showing that the SARS-CoV-2 Delta variant “is poised to acquire complete resistance” to the existing vaccines.
What’s more, when four common mutations were introduced to the Delta variant, Pfizer’s mRNA injection enhanced its infectivity, causing it to become resistant. A Delta variant with three mutations has already allegedly emerged, which suggests it’s only a matter of time before a fourth mutation develops, at which point complete resistance to Pfizer’s jab may be imminent.
The spike protein used in mRNA COVID-19 vaccines consists of the alleged original SARS-CoV-2 spike protein, without mutations. Multiple variants of concern (VOC) have allegedly emerged, however, which have numerous mutations and are highly infectious.
Dr. Lee Merritt: In Animal Studies, After Being Injected With mRNA Technology, All Animals Died Upon Reinfection.
As mutations increase, so do concerns over vaccine resistance and enhanced infectivity. As the researchers explained in bioRxiv, the preprint server for biology:
“The receptor binding domain (RBD) of the spike protein binds to the host cell receptor ACE2, and the interaction mediates membrane fusion during SARS-CoV-2 infection. Neutralizing antibodies against SARS-CoV-2 are mainly directed to the RBD and block the interaction between the RBD and ACE2. Most SARS-CoV-2 variants have acquired mutations in the neutralizing antibody epitopes of the RBD, resulting in escape from neutralizing antibodies.”
When a single mutation was added to the Delta spike, most of the anti-RBD antibodies still recognized it. This wasn’t the case with four mutations, however, which the researchers called Delta 4+. Not only was Delta 4+ not recognised, but infectivity was enhanced.
In short, while Pfizer’s Covid-19 jab still neutralised the Delta variant, when four common mutations were introduced to the RBD, the vaccine lost the ability to neutralize the variant and instead enhanced its infectivity.
“A third round of booster immunization with the SARS-CoV-2 vaccine is currently under consideration,” the researchers explained. “Our data suggest that repeated immunization with the wild-type spike may not be effective in controlling the newly emerging Delta variants.”
Despite the growing recognition that increasing injections may only make matters worse, Israel is currently carrying out a booster shot campaign after recently recording the highest rate of infections over 7 days in the world despite 80% of the population being fully vaccinated. The US and UK have also confirmed they are about to follow suit.
A number of experts have raised concerns that Covid-19 injections and the mass vaccination program could worsen the pandemic by triggering the development of new variants, via a concept known as antigenic, or immune, escape.
A general principle in biology, vaccinology and microbiology is that if you put living organisms like bacteria or viruses under pressure, via antibiotics, antibodies or chemotherapeutics, for example, but don’t kill them off completely, you can inadvertently encourage their mutation into more virulent strains. Those that escape your immune system end up surviving and selecting mutations to ensure their further survival.
Geert Vanden Bossche, Ph.D., a vaccinology expert and former global director of vaccine programs, including work for the Bill & Melinda Gates Foundation, is among those who have warned about immune escape due to the pressure being placed upon the virus during mass vaccination.
“It will have a very tough time … and a lot of these microorganisms will die,” Bossche says. “But if you cannot really kill them all, if you cannot prevent, completely, the infection and if there are still some microorganisms that can replicate despite this huge pressure, they will start to select mutations that enable them to survive.”
COVID-19 has a high capacity for mutation but, according to Bossche, if the virus isn’t under pressure, it won’t necessarily see a need to select mutations to, for instance, become more infectious. But if you put it under pressure, as is occurring during the mass vaccination campaign — or as Bossche calls it the “one big experiment” — this may change.”
https://www.biorxiv.org/content/10.1101/2021.08.22.457114v1.full
“Just because a pharmaceutical company labels something a “vaccination” does not mean the product will give people immunity for life and save them from certain death. The label of “vaccination” is not synonymous with immunization, especially when the “vaccine” is a new controversial technology for a virus serotype prone to rapid mutation and immunity escape.
Japanese researchers have published a new study on how the “fully vaccinated” will likely experience enhanced disease when re-exposed to wild-type coronavirus variants such as Delta. The study shows that the Delta variant of SARS-CoV-2 “is poised to acquire complete resistance” to the existing vaccine supply and will put the vaccinated at increased risk of severe illness.
The scientific phenomenon, known as antibody dependent enhancement, was first witnessed in animal trials for failed vaccines targeting SARS. After being injected with the mRNA technology, all animals died upon re-infection with wild-type virus. Because these new mRNA covid-19 vaccines were rushed through the FDA’s approval process, animal studies were skipped. That’s why many skeptics feel like we are the animal studies.
Pfizer’s mRNA vaccine spurs coronavirus mutations that the vaccine-induced antibodies eventually cannot recognize
In the study, the Delta variant was pressured into four common mutations. The Pfizer and Moderna spike proteins that are transcribed in human cells do not prepare the body to fight the new variants that are being pressured into existence by these same vaccine programs. In fact, the Pfizer vaccine enhances the infectivity of the variant, causing the virus to be even more resistant to the human immune system. Scientists have identified three mutations of SARS-CoV-2 that are already outsmarting Pfizer’s mRNA vaccine technology. According to this study, after a fourth mutation emerges dominant in the population, the vaccinated will become more susceptible to severe illness.
“The receptor binding domain (RBD) of the spike protein binds to the host cell receptor ACE2, and the interaction mediates membrane fusion during SARS-CoV-2 infection,” the study authors wrote. “Neutralizing antibodies against SARS-CoV-2 are mainly directed to the RBD and block the interaction between the RBD and ACE2. Most SARS-CoV-2 variants have acquired mutations in the neutralizing antibody epitopes of the RBD, resulting in escape from neutralizing antibodies.”
The vaccine was only effective for a short amount of time against a single mutation. Most of the anti-receptor binding domain antibodies (induced by the vaccine) were able to recognize the spike protein and prevent severe infection. However, after four mutations, the antibodies induced by the vaccine were unable to recognize the spike protein. Consequentially, infectivity of Delta 4+ was enhanced, as the vaccinated became immune-compromised and more susceptible to severe illness.
The public health response must evolve past faulty and dangerous vaccination programs
Worse yet, there’s now evidence that rates of SARS-CoV-2 transmission and vaccination drive the rapid evolution of vaccine-resistant strains. It’s only a matter of time before the public must accept that full exposure to these mutations is necessary in order to evolve the human immune response past the failure of this vaccine science. The public health response of the past almost two years has kept people locked down in anticipation of a savior vaccine program. As this program fails, the public health response must change, focusing instead on reducing inflammation in human cells, correcting underlying health issues, and enhancing the innate human immune response.
Previous exposure and naturally-acquired immunity to SARS-CoV-2 has already been shown to confer longer lasting immunity to these new variants. Researchers from Washington University School of Medicine provided evidence that previous exposure and recovery from SARS-CoV-2 infection imparts lifelong immunity, even when the infection is mild.
Hospitals and insurers are not in any position to see these changes through, so expect more malpractice, more attacks against the “unvaccinated” and more coding of vaccinated deaths as unvaccinated deaths. Booster shots are already being recommended, and Pfizer is gearing up to release yearly booster programs as they pressure unending mutations into existence. The current vax-all public health guidance is exacerbating severe disease and increasing hospitalization and death. This thing it nowhere never over now.”
Comments